text: <unk> (nasal) is a serotonin (5-HT1B/1D) receptor agonist that is FDA approved for the treatment of migraine with or without aura in adults.   Common adverse reactions include burning sensation, disorder/discomfort of nasal cavity/sinuses, throat discomfort, nausea and/or vomiting, bad/unusual taste, and dizziness/vertigo.
option_0: Sumatriptan 
option_1: Eletriptan
option_2: Frovatriptan
option_3: Rizatriptan
option_4: Almotriptan
option_5: Naratriptan
option_6: Zolmitriptan 
option_7: Atogepant